Grace Therapeutics, Inc.
GRCE· Nasdaq
GRCEGrace Therapeutics, Inc.
Filed Jun 22, 2021 · 10-K · 83 days after period end · 0001171843-21-004462
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|
| Net Income | -$5.65M | -$25.51M | -$39.37M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Grace Therapeutics, Inc. · CIK 1444192 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed Jun 22, 2021 · 83 d after period end
